NeuroVasx appoints distributor for Japan:
This article was originally published in Clinica
Executive Summary
Development-company NeuroVasx has appointed MDI Japan as distributor for its products there. The two companies hope to gain product registration in 1999. In November, NeuroVasx, of Plymouth, Minnesota, filed a 510(k) with the US FDA for its first product, the Sub-MicroInfusion catheter for the delivery of diagnostic agents to assess stroke. Separately, the US Patent and Trademark Office has allowed NeuroVasx a "substantial number of its claims" concerning its RPM macerator catheter. The product is used to combine the break-up of blood clots with the delivery of drugs for the treatment of acute stroke.